|
Showing the most relevant articles for your search:NYSE:FRX Date | Time | Source | Headline | Symbol | Company | 01/09/2004 | 11:04AM | PR Newswire (US) | Forest Laboratories to Exceed Fiscal 2004 Third Quarter Consensus and Guides Full Year to Top End of Previous Guidance | NYSE:FRX | Forest Road Acquisition Corp |
01/09/2004 | 11:03AM | PR Newswire (US) | Cypress Bioscience, Inc., Forest Laboratories, Inc. and Pierre Fabre Medicament Announce Development and Marketing Agreement for | NYSE:FRX | Forest Road Acquisition Corp |
01/08/2004 | 9:24AM | PR Newswire (US) | MORNING UPDATE: Man Securities Issues Alerts for NT, SCHN, FRX, RMBS, And SEPR | NYSE:FRX | Forest Road Acquisition Corp |
01/07/2004 | 8:00AM | PR Newswire (US) | Namenda(TM) (Memantine HCl) Mild to Moderate Alzheimer's Disease Studies Reported Today Forest Laboratories to Seek Approval for | NYSE:FRX | Forest Road Acquisition Corp |
12/18/2003 | 3:46PM | PR Newswire (US) | Lexapro(TM) Receives FDA Approval for the Treatment of Generalized Anxiety Disorder | NYSE:FRX | Forest Road Acquisition Corp |
12/10/2003 | 1:00PM | PR Newswire (US) | Starting Dose of Lexapro(TM) as Effective as Optimally Dosed Zoloft(R) in the Treatment of Major Depressive Disorder | NYSE:FRX | Forest Road Acquisition Corp |
12/03/2003 | 9:23AM | PR Newswire (US) | MORNING UPDATE: Man Securities Issues Alerts for ORCL, ALTR, ABX, FRX, And ADP | NYSE:FRX | Forest Road Acquisition Corp |
11/12/2003 | 4:28PM | PR Newswire (US) | Long-Term Treatment With Aerospan(TM) Has No Effect On Growth In Children With Mild Asthma | NYSE:FRX | Forest Road Acquisition Corp |
|
Showing the most relevant articles for your search:NYSE:FRX |
|